Targeting DNA damage and repair by curcumin

Breast Cancer: Basic and Clinical Research

Volumn 4, Issue 1, 2010, Pages 1-3

  Ji, Zhenyu ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Breast cancer cells; Curcumin; DNA damage

Indexed keywords

CURCUMIN;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; DNA DAMAGE; DNA REPAIR; DRUG SAFETY; GENE EXPRESSION; HUMAN; NONHUMAN; NOTE;

EID: 77953463275     PISSN: None     EISSN: 11782234     Source Type: Journal    
DOI: None     Document Type: Note

References (10)

1. Rowe DL, Ozbay T, O'Regan RM, Nahta R. Modulation of the BRCA1 Protein and Induction of Apoptosis in Triple Negative Breast Cancer Cell Lines by the Polyphenolic Compound Curcumin. Breast Cancer: Basic and Clinical Research. 2009 Sep;3:61-75.
2. Cheng AL, Hsu CH, Lin JK, et al. Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res. 2001 Jul Aug;21(4B):2895-900.
3. Chirnomas D, Taniguchi T, de la Vega M, et al. Chemosensitization to cisplatin by inhibitors of the Fanconi anemia/BRCA pathway. Mol Cancer Ther. 2006 Apr;5(4):952-61.
4. Lu HF, Yang JS, Lai KC, et al. Curcumin-induced DNA damage and inhibited DNA repair genes expressions in mouse-rat hybrid retina ganglion cells (N18). Neurochem Res. 2009 Aug;34(8):1491-7.
5. Litman R, Gupta R, Brosh RM Jr, Cantor SB. BRCA-FA pathway as a target for anti-tumor drugs. Anticancer Agents Med Chem. 2008 May;8(4): 426-30.
6. D'Andrea AD, Grompe M. The Fanconi anaemia/BRCA pathway. Nat Rev Cancer. 2003 Jan;3(1):23-34.
7. Thompson LH. Unraveling the Fanconi anemia-DNA repair connection. Nat Genet. 2005 Sep;37(9):921-2.
8. Xiao H, Zhang KJ. Antiproliferative effect of curcumin combined with cyclophosmide on the growth of human lymphoma cell line HT/CTX with drug resistance and its relation with FA/BRCA pathway. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2008 Aug;16(4):804-8.
9. Du B, Jiang L, Xia Q, Zhong L. Synergistic inhibitory effects of curcumin and 5-fluorouracil on the growth of the human colon cancer cell line HT-29. Chemotherapy. 2006;52(1):23-8.
10. Lev-Ari S, Strier L, Kazanov D, et al. Celecoxib and curcumin synergistically inhibit the growth of colorectal cancer cells. Clin Cancer Res. 2005 Sep 15;11(18):6738-44.